IL17A and Granuloma: However, exogenous addition of IL-17 during cell-cell fusion assay did not affect the fusion rate induced by ConA/IFN-γ, suggesting that the decrease of MGCs in etanercept-treated Mtb-induced granuloma is not related to increased IL-17.